Cargando…
Could MAO-B Inhibitor Withdrawal Rather than Nilotinib Benefit Explain the Dopamine Metabolite Increase in Parkinsonian Study Subjects?
Autor principal: | Schwarzschild, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302030/ https://www.ncbi.nlm.nih.gov/pubmed/28035939 http://dx.doi.org/10.3233/JPD-160975 |
Ejemplares similares
-
Review: Subjective Time Perception, Dopamine Signaling, and Parkinsonian Slowness
por: Miyawaki, Edison K.
Publicado: (2022) -
Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis
por: Cho, Hyun-U, et al.
Publicado: (2021) -
Dopamine Precursor Depletion Influences Pain Affect Rather than Pain Sensation
por: Tiemann, Laura, et al.
Publicado: (2014) -
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020) -
Incomplete lineage sorting rather than hybridization explains the inconsistent phylogeny of the wisent
por: Wang, Kun, et al.
Publicado: (2018)